Bayer Extends Research Collaboration for Cancer Therapies

Bayer Extends Functional Genomics Research Collaboration with ...

NEW YORK, June 19 - An ongoing agreement Paradigm Genetics has with Bayer to perform contract research in functional genomics was extended ...

Bayer and Tempus Initiate Collaboration to Advance Patient Access ...

Bayer and Tempus, leaders in precision medicine and artificial intelligence (AI), announced a new collaboration designed to provide broader ...

Huma and Bayer to advance precision lung cancer treatment

Our collaboration leverages Huma's proven expertise in Machine Learning and Bayer's vast capabilities in Oncology and Medical Imaging to help ...

Bayer Begins Phase III NSCLC Trial - Patsnap Synapse

In February 2024, the U.S. Food and Drug Administration (FDA) designated BAY 2927088 as a Breakthrough Therapy for second-line treatment.

University of Pittsburgh and Bayer Form Research Alliance for New ...

Partnership Expands For Discovery Of Novel Cancer Treatments - Drug Discovery and Development · Partnership Formed to Advance Bioelectronic ...

Bayer extends Partnership with Peking University to foster ...

Beijing, July 10, 2023 –Bayer and Peking University (PKU) will collaborate to foster the translation of basic pharmaceutical research into ...

Bayer AG - Access to Medicine Foundation

Research and Development ... Access planning processes encompass all projects in the pipeline. Bayer has a structured process in place to develop access plans ...

Science in Boston on LinkedIn: Bayer and Broad Institute extend ...

Bayer and the Broad Institute of MIT and Harvard have renewed their research alliance, adding five years to a ten-year collaboration that ...

Bayer's Vividion unit forges $930m cancer alliance with Tavros

Earlier this year, Bayer reached a deal to acquire Noria Therapeutics and its subsidiary PSMA Therapeutics, adding to its pipeline of ...

Bayer Expands Collaboration with Peking University - CHEManager

The cooperation will focus on oncology, cardiorenal, immunology, and cell and gene therapy. Bayer will provide the funds and support for the ...

Ventana And Bayer Extend Collaboration - Med Device Online

... therapies in the Bayer development portfolio. ... cancer diagnostics. VENTANA products are used in clinical histology and drug development research laboratories ...

Bayer Expands Precision Oncology Portfolio with MOMA ...

Bayer and MOMA Therapeutics have announced a new collaboration aimed at advancing precision cancer treatments. The partnership will focus on ...

Boehringer Ingelheim Bayer Extend Access To Clinical Trial Data

Bayer HealthCare announced in a press release it will provide qualified researchers access to its clinical studies through an internet portal.

Bayer, Aignostics Using AI Tools, Algorithms to Advance Precision ...

The firms will build a target identification platform and develop computational pathology algorithms for patient stratification.

Bayer backs out of Atara cell therapy deal - BioPharma Dive

Bayer plans stop developing cancer cell therapies with Atara Biotherapeutics, informing the California biotech company that it will ...

Regeneron and Bayer Start Phase 3 Trial to Extend Ophthalmology ...

Regeneron and Bayer Start Phase 3 Trial to Extend Ophthalmology Research & Development Program for VEGF Trap-Eye in Asia ... TARRYTOWN, N.Y. , ...

Ventana and Bayer Extend Collaboration - AZBio

This new agreement extends an already existing collaboration and focuses on the development of diagnostic tests for Bayer's biomarker targeted ...

Bayer and Tempus Initiate Collaboration to Advance Patient ... - News

Bayer and Tempus, leaders in precision medicine and artificial intelligence (AI), announced a new collaboration designed to provide broader ...

NCI Cancer Tissue Engineering Collaborative (TEC)

The Cancer TEC Research Program catalyzes the advancement of innovative, well characterized in vitro and ex vivo systems available for cancer ...

ReCode Therapeutics Announces Strategic Collaboration with ...

Collaboration will combine ReCode's unique delivery technology with AskBio's gene editing and DNA cargoes to develop novel gene correction therapies for the ...